Latest News about PRFX
Recent news which mentions PRFX
The Daily Biotech Pulse: CureVac COVID-19 Vaccine Deal, Argenx Out-Licenses Neuromuscular Disorder Drug, Xencor's Oncology Collaboration
January 07, 2021
From Benzinga
40 Stocks Moving in Friday's Pre-Market Session
December 18, 2020
From Benzinga
80 Biggest Movers From Yesterday
December 18, 2020
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 17, 2020
From Benzinga
50 Stocks Moving In Thursday's Mid-Day Session
December 17, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
December 17, 2020
From Benzinga
12 Healthcare Stocks Moving In Monday's After-Market Session
November 23, 2020
From Benzinga
The Daily Biotech Pulse: Five Prime Skyrockets, Multiple Conference Presentations On Tap
November 11, 2020
From Benzinga
56 Biggest Movers From Yesterday
October 16, 2020
From Benzinga
The Daily Biotech Pulse: Mesoblast Slumps On FDA Rejection, AstraZeneca's Breakthrough Therapy Designation, 3 IPOs
October 02, 2020
From Benzinga
The Daily Biotech Pulse: Eton Snags Second FDA Nod For Month, Vaccine Updates from Moderna, CureVac
September 30, 2020
From Benzinga
The Daily Biotech Pulse: FDA Nod For Pfizer, Sorrento's COVID-19 Antibody Animal Data, Orphazyme's Wall Street Debut
September 29, 2020
From Benzinga
The Week Ahead In Biotech: FDA Decisions For Mesoblast And Eton, Coronavirus Vaccine Updates
September 26, 2020
From Benzinga
The Daily Biotech Pulse: Novavax Advances Vaccine, Marinus Gets Nod For Late-Stage Study, 3 IPOs
September 25, 2020
From Benzinga
The Daily Biotech Pulse: Gilead's $7.25B Debt Offering, Lexicon Deleverages, Taysha Gene Therapies Prices IPO
September 24, 2020
From Benzinga
The Daily Biotech Pulse: Coronavirus Vaccine Updates From J&J & MediciNova, Australian Regulatory Nod For GW Pharma
September 23, 2020
From Benzinga
The Week Ahead In Biotech: Conference Presentations, IPOs In The Mix
September 20, 2020
From Benzinga
The Daily Biotech Pulse: Moderna Inks 2 R&D Deals, BioNTech To Buy Manufacturing Facility, Dyne Therapeutics IPO
September 17, 2020
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.